We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Siddharth Srivastava

Siddharth Srivastava MD

Assistant Professor of Neurology, Harvard Medical School; Pediatric Neurologist, Boston Children's Hospital, Boston, Massachusetts

Dr. Siddharth Srivastava is an Assistant Professor of Neurology at Harvard Medical School and a pediatric neurologist at Boston Children's Hospital specializing in neurogenetics and neurodevelopmental disabilities.

His research involves studying different genetic causes of neurodevelopmental disorders -- such as intellectual disability and cerebral palsy -- in order to develop targeted treatments. He utilizes a multi-model approach encompassing (1) gene discovery, (2) neurodevelopmental phenotyping, and (3) biomarker identification. This approach not only pinpoints possible mechanisms of disease but also delineates appropriate targets for therapy in future clinical trials aimed at improving developmental outcomes. One of his current projects is funded by the NIH (K23) and focuses on the genetics of cerebral palsy. He hopes to improve the lives of children with neurogenetic and neurodevelopmental disorders by translating these scientific discoveries into meaning clinical practice changes.

At Boston Children's Hospital, he provides care to children in a variety of neurodevelopmental and neurogenetics clinics. He takes part in the Developmental Neurogenetics Program, which specializes in the diagnosis and management of genetic disorders associated with neurodevelopmental disabilities. Within this program, some of the specific genetic disorders he follows include Phelan McDermid Syndrome, PTEN Hamartoma Tumor Syndrome, and Kleefstra Syndrome. He also evaluates and treats patients in the Cerebral Palsy Program, where one of his goals is to diagnose genetic disorders presenting as cerebral palsy.

He received his BA degree in biochemistry from Columbia University and his MD degree from Johns Hopkins University School of Medicine. He finished a combined residency in pediatrics and neurodevelopmental disabilities at Johns Hopkins Hospital and the Kennedy Krieger Institute. He completed a fellowship in neurogenetics at Boston Children's Hospital.

Disclosures

Dr. Srivastava has received consulting fees from GLG, Guidepoint (which connected to a client, Fortress Biotech), Novartis, ExpertConnect, and Orchard Therapeutics.